Contents

Current Topics in Medicinal Chemistry, Volume 17 - Number 1

Preface

Preface

, 17(1): 1

Allen B. Reitz


DOI: 10.2174/156802661701161114211346




Editorial

Editorial (Thematic Issue: New Targets for Structure-Based Drug Discovery)

, 17(1): 2 - 3

Steve Andrews and Miles Congreve


DOI: 10.2174/156802661701161114211740




Review Article

Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery

, 17(1): 4 - 15

Kenneth K. Hallenbeck, David M. Turner, Adam R. Renslo and Michelle R. Arkin


DOI: 10.2174/1568026616666160719163839





Review Article

Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design

, 17(1): 16 - 29

Wenye Zhao, Mostafa Jamshidiha, Thomas Lanyon-Hogg, Chiara Recchi, Ernesto Cota and Edward W. Tate


DOI: 10.2174/1568026616666160719165633





Review Article

Structure Based Design of CYP51 Inhibitors

, 17(1): 30 - 39

Jun Yong Choi and William R. Roush


DOI: 10.2174/1568026616666160719164933





Review Article

Structure-Based Rational Design of Adenosine Receptor Ligands

, 17(1): 40 - 58

Hugo Gutiérrez-de-Terán, Jessica Sallander and Eddy Sotelo


DOI: 10.2174/1568026616666160719164207





Review Article

Expanding the Opportunities for Modulating Kinase Targets with Allosteric Approaches

, 17(1): 59 - 70

Henrik Mobitz, Wolfgang Jahnke and Sandra W. Cowan-Jacob


DOI: 10.2174/1568026616666160719165314





Review Article

Potential for the Rational Design of Allosteric Modulators of Class C GPCRs

, 17(1): 71 - 78

John A. Christopher, Andrew S. Doré and Benjamin G. Tehan


DOI: 10.2174/1568026616666160719165922





Review Article

New Opportunities in the Structure-based Design of Anti-Protozoan Agents

, 17(1): 79 - 90

James A. Gordon, Colin W.G. Fishwick and Martin J. McPhillie


DOI: 10.2174/1568026616666160719164542





Corrigendum

, 17(1): 91


DOI: 10.2174/156802661701161114223616




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science